| 000 | 01539 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511182032.0 | ||
| 264 | 0 | _c19920728 | |
| 008 | 199207s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/ijc.2910510519 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRappa, G | |
| 245 | 0 | 0 |
_aPotentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26). _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cJul 1992 |
||
| 300 |
_a780-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAmsacrine _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDNA _xbiosynthesis |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type II _xmetabolism |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNovobiocin _xadministration & dosage |
| 650 | 0 | 4 |
_aRNA _xbiosynthesis |
| 650 | 0 | 4 |
_aTeniposide _xadministration & dosage |
| 650 | 0 | 4 | _aTopoisomerase II Inhibitors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aLorico, A | |
| 700 | 1 | _aSartorelli, A C | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 51 _gno. 5 _gp. 780-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.2910510519 _zAvailable from publisher's website |
| 999 |
_c1383676 _d1383676 |
||